Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rashid S et al. – Results indicate for the first time in humans that phospholipid and cholesterol efflux are 2 separate and distinct processes in cellular high-density lipoprotein (HDL) biosynthesis and that normal cellular phospholipid efflux is necessary for formation of larger {alpha}-HDL particles. Defective ABCA1 protein regulation results in a defect in phospholipid efflux, treatable with physiological oxysterols, a current therapeutic target that may serve to raise HDL levels in severe HDL deficiencies, pending further study.

Methods

Results

   

Today in Atherosclerosis/Lipids...keeping you current

Small, dense LDL cholesterol and apolipoprotein B: Relationship with serum lipids and LDL size
Atherosclerosis, 12/03/09

Management of non-high-density lipoprotein abnormalities
Atherosclerosis, 12/03/09

The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Atherosclerosis, 12/03/09